NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $480,000 | -60.8% | 89,000 | -1.9% | 0.00% | -50.0% |
| Q4 2021 | $1,225,000 | -0.9% | 90,700 | +30.8% | 0.01% | -11.1% |
| Q3 2021 | $1,236,000 | +22.5% | 69,321 | +16.9% | 0.01% | +12.5% |
| Q2 2021 | $1,009,000 | -21.5% | 59,321 | -7.7% | 0.01% | -33.3% |
| Q1 2021 | $1,286,000 | +26.5% | 64,300 | +7.5% | 0.01% | +20.0% |
| Q4 2020 | $1,017,000 | +5.2% | 59,800 | +2.6% | 0.01% | -9.1% |
| Q3 2020 | $967,000 | -33.3% | 58,300 | -6.8% | 0.01% | -38.9% |
| Q2 2020 | $1,449,000 | +29.7% | 62,550 | 0.0% | 0.02% | +12.5% |
| Q1 2020 | $1,117,000 | -7.7% | 62,550 | +11.6% | 0.02% | +23.1% |
| Q4 2019 | $1,210,000 | +296.7% | 56,050 | +553.6% | 0.01% | +225.0% |
| Q3 2019 | $305,000 | 0.0% | 8,575 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $305,000 | +7.0% | 8,575 | +1.2% | 0.00% | 0.0% |
| Q1 2019 | $285,000 | – | 8,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |